ES539349A0 - Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina - Google Patents

Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina

Info

Publication number
ES539349A0
ES539349A0 ES539349A ES539349A ES539349A0 ES 539349 A0 ES539349 A0 ES 539349A0 ES 539349 A ES539349 A ES 539349A ES 539349 A ES539349 A ES 539349A ES 539349 A0 ES539349 A0 ES 539349A0
Authority
ES
Spain
Prior art keywords
stearium
erythromycin
acetyl
preparation
antibiotic compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES539349A
Other languages
English (en)
Other versions
ES8605818A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Publication of ES8605818A1 publication Critical patent/ES8605818A1/es
Publication of ES539349A0 publication Critical patent/ES539349A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
ES539349A 1984-01-06 1985-01-04 Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina Expired ES8605818A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (2)

Publication Number Publication Date
ES8605818A1 ES8605818A1 (es) 1986-04-01
ES539349A0 true ES539349A0 (es) 1986-04-01

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539349A Expired ES8605818A1 (es) 1984-01-06 1985-01-04 Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina

Country Status (38)

Country Link
US (1) US4599326A (es)
JP (1) JPS60158197A (es)
KR (1) KR900006237B1 (es)
AT (1) AT386414B (es)
AU (1) AU565688B2 (es)
BE (1) BE901411A (es)
BG (1) BG43189A3 (es)
CA (1) CA1224461A (es)
CH (1) CH666275A5 (es)
CS (1) CS247191B2 (es)
CY (1) CY1462A (es)
DE (1) DE3500179A1 (es)
DK (1) DK149776C (es)
ES (1) ES8605818A1 (es)
FI (1) FI77249C (es)
FR (1) FR2557878B1 (es)
GB (1) GB2152502B (es)
HK (1) HK11590A (es)
HU (1) HU196221B (es)
IE (1) IE57967B1 (es)
IL (1) IL73885A (es)
IS (1) IS2968A7 (es)
IT (1) IT1184304B (es)
KE (1) KE3841A (es)
LU (1) LU85721A1 (es)
MA (1) MA20316A1 (es)
MX (1) MX156277A (es)
NL (1) NL8403979A (es)
NO (1) NO160263C (es)
NZ (1) NZ210606A (es)
PH (1) PH22471A (es)
PL (1) PL144349B1 (es)
PT (1) PT79777B (es)
RO (1) RO91262B (es)
SE (1) SE461854B (es)
SU (1) SU1410866A3 (es)
YU (1) YU44485B (es)
ZA (1) ZA8410143B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル， インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
KR20060109922A (ko) * 2003-10-31 2006-10-23 알자 코포레이션 가바펜틴 및 프리가발린의 개선된 흡수를 위한 조성물 및제형
SI1765292T1 (en) 2004-06-12 2018-04-30 Collegium Pharmaceutical, Inc. Formulations of medicines to discourage abuse
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
EP2158898A1 (en) 2006-06-23 2010-03-03 Aegis Therapeutics LLC Stabilizing alkylglycoside compositions and method thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP6148228B2 (ja) 2011-05-18 2017-06-14 ユーメデリス ファーマシューティカルズ，インク． 改善されたペプチド製剤
JP6525456B2 (ja) 2012-11-20 2019-06-05 メデリス ダイアビーティーズ，エルエルシー インスリン抵抗性のための改善されたペプチド製剤
EP3444281B1 (en) 2012-11-20 2021-11-03 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
KR20230084337A (ko) 2014-05-28 2023-06-12 메더리스 다이어비티즈, 엘엘씨 인슐린 저항성에 대한 개선된 펩티드 약제
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
EP3624840A4 (en) 2017-05-19 2021-03-10 Lunella Biotech, Inc. ANTIMITOSCINE: TARGETED INHIBITORS OF MITOCHONDRIAL BIOGENESIS TO DESCRIBE CANCER STEM CELLS
WO2019108729A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
KR20220035512A (ko) 2018-02-06 2022-03-22 이지스 쎄라퓨틱스, 엘엘씨 비강내 에피네프린 제제 및 질환의 치료 방법
PE20220499A1 (es) * 2018-12-17 2022-04-07 Lunella Biotech Inc Terapias de combinacion triple para anti-envejecimiento
BR112021011963A2 (pt) * 2018-12-17 2021-09-08 Lunella Biotech, Inc. Terapias de combinação tripla para alvejamento de mitocôndria e exterminação de células-tronco de câncer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
RO91262B (ro) 1987-07-01
IL73885A (en) 1988-10-31
IE57967B1 (en) 1993-06-02
FI850023L (fi) 1985-07-07
FR2557878A1 (fr) 1985-07-12
NL8403979A (nl) 1985-08-01
PH22471A (en) 1988-09-12
MX156277A (es) 1988-08-04
MA20316A1 (fr) 1985-10-01
GB2152502B (en) 1987-10-07
KE3841A (en) 1989-04-07
NO160263B (no) 1988-12-19
YU44485B (en) 1990-08-31
AT386414B (de) 1988-08-25
SE461854B (sv) 1990-04-02
SE8406671D0 (sv) 1984-12-28
DK5884A (da) 1985-07-07
FI77249B (fi) 1988-10-31
FI77249C (fi) 1989-02-10
NO160263C (no) 1989-03-29
US4599326A (en) 1986-07-08
SE8406671L (sv) 1985-07-07
AU3705984A (en) 1985-07-11
IL73885A0 (en) 1985-03-31
DE3500179A1 (de) 1985-07-18
JPH029040B2 (es) 1990-02-28
PL144349B1 (en) 1988-05-31
ZA8410143B (en) 1985-08-28
HU196221B (en) 1988-10-28
YU2085A (en) 1987-12-31
AU565688B2 (en) 1987-09-24
GB8432368D0 (en) 1985-02-06
CA1224461A (en) 1987-07-21
BG43189A3 (en) 1988-04-15
DE3500179C2 (es) 1989-08-24
IT1184304B (it) 1987-10-28
PT79777A (en) 1985-01-01
KR900006237B1 (ko) 1990-08-27
ES8605818A1 (es) 1986-04-01
CH666275A5 (de) 1988-07-15
NZ210606A (en) 1987-08-31
PT79777B (en) 1986-10-21
DK149776B (da) 1986-09-29
SU1410866A3 (ru) 1988-07-15
ATA985A (de) 1988-01-15
RO91262A (ro) 1987-06-30
IE850022L (en) 1985-07-06
NO850007L (no) 1985-07-08
GB2152502A (en) 1985-08-07
CY1462A (en) 1989-07-21
CS247191B2 (en) 1986-12-18
PL251457A1 (en) 1985-11-05
BE901411A (fr) 1985-04-16
IS2968A7 (is) 1985-04-03
LU85721A1 (fr) 1985-07-24
DK5884D0 (da) 1984-01-06
FI850023A0 (fi) 1985-01-03
HK11590A (en) 1990-02-23
DK149776C (da) 1987-04-21
FR2557878B1 (fr) 1988-01-15
IT8519012A0 (it) 1985-01-04
KR850005452A (ko) 1985-08-26
JPS60158197A (ja) 1985-08-19
HUT37628A (en) 1986-01-23

Similar Documents

Publication Publication Date Title
ES539349A0 (es) Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES540366A0 (es) Un procedimiento para la preparacion de un compuesto
ES541200A0 (es) Un procedimiento para la preparacion de un derivado de dibenzoilmetano.
ES545756A0 (es) Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES551503A0 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
ES498922A0 (es) Un procedimiento para la preparacion de compuestos de polie-ter antibioticos
ES536455A0 (es) Un procedimiento para la preparacion de un antibiotico bbm-2478.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES539853A0 (es) Un procedimiento para la preparacion de nuevos derivados penem.
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES531792A0 (es) Un procedimiento para la preparacion de un compuesto.
ES539543A0 (es) Un procedimiento para la preparacion de nuevos compuestos de oxadiazinona.
AR230283A1 (es) Un procedimiento para la preparacion de un derivado de 4a,9b-trans-hexahidro-ih-piridoindol enantiomerico(+)o racemico(=)
ES542613A0 (es) Un procedimiento para la preparacion de compuesto denominado cl-1724b-2
AR227730A1 (es) Un procedimiento para la produccion de un antibiotico
ES545053A0 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihi- droorotil-histidil-prolinamida
ES541373A0 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
ES534066A0 (es) Un procedimiento para la preparacion de antibioticos de b-lactama.
ES528986A0 (es) Un procedimiento para la preparacion de un compuesto de beta-lactama.
ES540590A0 (es) Un procedimiento para la produccion de enol-esteres de oxi- cams.
ES520971A0 (es) Un procedimiento para la preparacion de antibioticos b-lactamicos.
ES539854A0 (es) Un procedimiento para la preparacion de nuevos derivados penem.
ES548244A0 (es) Un procedimiento para la preparacion de derivados de 5-cetomilbemicina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401